CD19 and acute myeloid leukemia: Considering the frequent expression of CD19 in t(8;21) AML patients, the present study is aimed to investigate the efficacy and safety of CD19 CAR-T cell therapy in R/R t(8;21) AML with aberrant CD19 expression.